Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 1
1991 2
1992 3
1993 3
1994 2
1995 1
1997 2
1998 1
1999 1
2000 2
2001 1
2002 2
2003 2
2004 3
2005 1
2006 2
2007 1
2008 2
2010 2
2011 1
2012 4
2013 1
2014 3
2015 5
2017 2
2018 1
2019 5
2020 4
2021 4
2022 3
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Gain-of-function mutant p53: history and speculation.
Bargonetti J, Prives C. Bargonetti J, et al. J Mol Cell Biol. 2019 Jul 19;11(7):605-609. doi: 10.1093/jmcb/mjz067. J Mol Cell Biol. 2019. PMID: 31283823 Free PMC article. Review. No abstract available.
p53 domains: structure, oligomerization, and transformation.
Wang P, Reed M, Wang Y, Mayr G, Stenger JE, Anderson ME, Schwedes JF, Tegtmeyer P. Wang P, et al. Mol Cell Biol. 1994 Aug;14(8):5182-91. doi: 10.1128/mcb.14.8.5182-5191.1994. Mol Cell Biol. 1994. PMID: 8035799 Free PMC article.
Wild-type p53 forms tetramers and multiples of tetramers. Friedman et al. (P. N. Friedman, X. B. Chen, J. Bargonetti, and C. Prives, Proc. Natl. Acad. Sci. USA 90:3319-3323, 1993) have reported that human p53 behaves as a larger molecule during gel filtration than it does …
Wild-type p53 forms tetramers and multiples of tetramers. Friedman et al. (P. N. Friedman, X. B. Chen, J. Bargonetti, and C. Prives, …
In vitro inhibitory activity of RepC/C*, the inactivated form of the pT181 plasmid initiation protein, RepC.
Jin R, Rasooly A, Novick RP. Jin R, et al. J Bacteriol. 1997 Jan;179(1):141-7. doi: 10.1128/jb.179.1.141-147.1997. J Bacteriol. 1997. PMID: 8981991 Free PMC article.
This is consistent with previous measurements of the rate of RepC synthesis, which suggested that one RepC dimer is synthesized per replication event (J. Bargonetti, P.-Z. Wang and R. P. Novick, EMBO J. 12:3659-3667, 1993). ...
This is consistent with previous measurements of the rate of RepC synthesis, which suggested that one RepC dimer is synthesized per replicat …
Splice variants of MDM2 in oncogenesis.
Rosso M, Okoro DE, Bargonetti J. Rosso M, et al. Subcell Biochem. 2014;85:247-61. doi: 10.1007/978-94-017-9211-0_14. Subcell Biochem. 2014. PMID: 25201199 Review.
Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53.
Bargonetti J, Reynisdóttir I, Friedman PN, Prives C. Bargonetti J, et al. Genes Dev. 1992 Oct;6(10):1886-98. doi: 10.1101/gad.6.10.1886. Genes Dev. 1992. PMID: 1398068 Free article.
Wild-type p53 protein was shown to bind specifically to DNA sequences within SV40 (Bargonetti et al. 1991), the human ribosomal gene cluster (RGC) (Kern et al. 1991a), and the murine muscle creatine kinase gene (MCK) (Zambetti et al. 1992). ...
Wild-type p53 protein was shown to bind specifically to DNA sequences within SV40 (Bargonetti et al. 1991), the human ribosomal gene …
MDM2-C Functions as an E3 Ubiquitin Ligase.
Kim JY, Lee R, Xiao G, Forbes D, Bargonetti J. Kim JY, et al. Cancer Manag Res. 2020 Aug 24;12:7715-7724. doi: 10.2147/CMAR.S260943. eCollection 2020. Cancer Manag Res. 2020. PMID: 32904724 Free PMC article.
Multiple roles of the tumor suppressor p53.
Bargonetti J, Manfredi JJ. Bargonetti J, et al. Curr Opin Oncol. 2002 Jan;14(1):86-91. doi: 10.1097/00001622-200201000-00015. Curr Opin Oncol. 2002. PMID: 11790986 Review.
PARP-Targeted Auger Therapy in p53 Mutant Colon Cancer Xenograft Mouse Models.
Wilson T, Pirovano G, Xiao G, Samuels Z, Roberts S, Viray T, Guru N, Zanzonico P, Gollub M, Pillarsetty NVK, Reiner T, Bargonetti J. Wilson T, et al. Mol Pharm. 2021 Sep 6;18(9):3418-3428. doi: 10.1021/acs.molpharmaceut.1c00323. Epub 2021 Jul 28. Mol Pharm. 2021. PMID: 34318678 Free PMC article.
64 results